Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Thyroid nodules - stepwise diagnosis and management..
Hormones (Athens). 6(2), 101-19.
(2007). Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatide..
Eur J Endocrinol. 158(3), 411-5.
(2008). Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis..
Endocr J. 55(3), 613-6.
(2008). Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone..
J Bone Miner Metab. 26(6), 635-41.
(2008). Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules..
J Cancer Res Clin Oncol. 134(9), 953-60.
(2008). Subendothelial carotid hematoma after fine-needle aspiration biopsy of a solitary thyroid nodule..
J Ultrasound Med. 27(10), 1517-20.
(2008).
(2008). Clinical complications following thyroid fine-needle biopsy: a systematic review..
Clin Endocrinol (Oxf). 71(2), 157-65.
(2009). Histological alterations following thyroid fine needle biopsy: a systematic review..
Diagn Cytopathol. 37(6), 455-65.
(2009). Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways..
Med Hypotheses. 72(5), 610.
(2009). No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial..
Clin Endocrinol (Oxf). 70(4), 522-6.
(2009). Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines..
Curr Mol Med. 9(3), 299-314.
(2009). Paget's disease of bone: emphasis on treatment with zoledronic acid..
Expert Rev Endocrinol Metab. 4(5), 423-434.
(2009). RANKL inhibition for the management of patients with benign metabolic bone disorders..
Expert Opin Investig Drugs. 18(8), 1085-102.
(2009). Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid..
Support Care Cancer. 17(10), 1329-30.
(2009). Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin..
Med Hypotheses. 74(6), 1089-90.
(2010). Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis..
Hepatol Res. 40(4), 446-7.
(2010). Alterations in serum thyroid-related constituents after thyroid fine-needle biopsy: a systematic review..
Thyroid. 20(3), 265-71.
(2010). Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1..
J Clin Densitom. 13(2), 190-6.
(2010). The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis..
Clin Endocrinol (Oxf). 72(6), 752-7.
(2010). Infectious thyroiditis as a complication of fine-needle biopsy: a systematic review..
Expert Rev Endocrinol Metab. 5(5), 673-679.
(2010). Normochromic normocytic anemia in a postmenopausal woman with severe osteoporosis treated with intermittent parathyroid hormone..
J Bone Miner Metab. 28(1), 108-10.
(2010). Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a man..
Arq Bras Endocrinol Metabol. 54(6), 578-82.
(2010). Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease..
J Bone Miner Metab. 28(6), 706-12.
(2010). The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease..
Diabetes Obes Metab. 12(5), 365-83.
(2010).